This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Horizon Pharma PLC (HZNP)

NASDAQ: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 757.04M 296.95M 103.00M 22.98M
Cost of Sales 62.35M 26.45M 14.62M 7.12M
Gross Operating Profit 694.70M 270.50M 88.37M 15.85M
Selling, General, and Administrative Expenses 440.31M 209.23M 92.16M 69.00M
Research & Development 41.87M 17.46M 10.08M 16.84M
Operating Income before D & A (EBITDA) 212.53M 43.81M -13.88M -69.99M
Depreciation & Amortization 157.15M 52.30M 26.55M 5.54M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -118.18M -237.37M -97.07M -2.91M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -62.81M -245.86M -137.50M -78.44M
Interest Expense 69.90M 23.83M 39.18M 14.53M
Pre-Tax Income -132.71M -269.69M -176.68M -92.97M
Income Taxes -172.24M -6.08M -1.12M -5.17M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 39.53M -263.60M -149.00M -87.79M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 39.53M -263.60M -149.00M -87.79M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 39.53M -263.60M -149.00M -87.79M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
39.53M -263.60M -149.00M -87.79M
Preferred Dividends
Net Income Available To Common 39.53M -263.60M -149.00M -87.79M
Basic EPS from Continuing Ops. 0.27 -3.15 -2.34 -2.26
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.27 -3.15 -2.34 -2.26
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.27 -3.15 -2.34 -2.26
Basic Normalized Net Income/Share 0.27 -3.15 -2.34 -2.26
EPS fr Continuing Ops. 0.25 -3.15 -2.34 -2.26
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.25 -3.15 -2.34 -2.26
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.25 -3.15 -2.34 -2.26
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.25 -3.15 -2.34 -2.26
Dividends Paid per Share 0.00 0.00 0.00 0.00
HZNP News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

HZNP Horizon Pharma PLC

Chart of HZNP

Analysts Ratings for HZNP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET HZNP ANALYST REPORT

HZNP Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs